SkyAI, Inc. STSS

Full chart Compare
Set alert

Price alert · STSS

All alert types
1.27 USD 0.00 (+0.00%)

Aug 5, 2026, 3:59 PM EDT

1.22 Day range 1.32

52-week range unavailable

YTD
-37.44%
1 year
-78.44%
Market cap
53.75M
Shares out
1.80M
Forward P/E
-12.33
YTD return
-37.44%
1-year return
-78.44%
Volume
4.83K
Open
1.28
Previous close
1.27
Day's range
1.22 – 1.32
Beta
1.19

5Y -15,178.23 (-99.99%)

05,00010,00015,000202220232024202520261.77

Key statistics

Enterprise value
1.96M
PEG ratio
0.00
Price / sales
0.00
Price / book
0.16
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-6.38M
Total cash
1.48M
Total debt
0
Return on equity
-103.21%
Short % of float
2.49%
50-day average
2.76
200-day average
5.14

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
STSS Revenue — quarterly 3.33M
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026
STSS Net income — quarterly -86.24M
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026
STSS EPS — quarterly -1.19
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026

Earnings

STSS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 20240.00-1.27——
Aug 14, 2024Jun 1, 20240.00-2.20——
May 14, 2024Mar 1, 20240.00-1.10——

Upgrades / downgrades

STSS analyst upgrades and downgrades
DateFirmActionFromTo
May 9, 2023Aegis Capitalinit—Buy

About SkyAI, Inc.

Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on STSS — it syncs with the Stock Master app.

Insider holders

STSS insider holders
InsiderRelationLatest transactionDateShares held
CRESCENZO ANDREW RChief Financial OfficerPurchaseDec 27, 202315,500
HAYES ROBERT MICHAELChief Executive OfficerPurchaseFeb 19, 202495,882
RUEMLER TIMOTHY JAMESDirectorPurchaseJan 2, 20241,061,680

Institution ownership

STSS institution ownership
Holder% heldSharesValueReported
Essential Planning, Llc. 0.41%7,40113.69KSep 29, 2024
Renaissance Technologies, LLC0.35%6,22111.51KSep 29, 2024
Org Partners LLC 0.25%4,5488.41KSep 29, 2024
AlphaCore Capital, LLC0.22%4,0267.45KSep 29, 2024
Compass Ion Advisors, LLC0.14%2,5974.80KSep 29, 2024
HRT Financial LP0.09%1,6443.04KSep 29, 2024

Fund ownership

STSS fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.03%453838Jun 29, 2024